UroGen Pharma
URGN
URGN
128 hedge funds and large institutions have $446M invested in UroGen Pharma in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
+13
Holders Change %
+11.3%
% of All Funds
1.85%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
25
Increased
51
Reduced
29
Closed
12
Calls
$323K
Puts
$1.83M
Net Calls
-$1.5M
Net Calls Change
-$451K
Top Buyers
| 1 |
1
Adage Capital Partners
Boston,
Massachusetts
|
$47.4M |
| 2 |
VPC
2
Vestal Point Capital
New York
|
$5.08M |
| 3 |
3
Morgan Stanley
New York
|
$27.7M |
| 4 |
4
Millennium Management
New York
|
$19M |
| 5 |
5
BlackRock
New York
|
$31.7M |
